Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners by taking oral antiretroviral medicines when their immune systems were relatively healthy, according to findings from a large-scale clinical study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

NSW Health is calling for business owners and occupiers to ensure cooling towers are maintained and treated after a steady rise in the number of Legionnaires' disease cases reported over the past two months, with 24 Legionella pneumophila cases in March and April compared to 8 cases in the same period last year.

The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.

A new study published in the journal Respirology reveals that adult patients admitted to the hospital with pneumonia are more likely to die if they have vitamin D deficiency.

A widely used HIV drug could be used to prevent cervical cancer caused by infection with the human papilloma virus (HPV), say scientists.

Deadly human fungal infections caused by certain strains of Aspergillus fungi appear to be developing resistance to current drug treatments at an alarming rate, say scientists.

Imagine a battlefield medic or emergency medical technician providing first aid with a special wad of cottony glass fibres that simultaneously slows bleeding, fights bacteria (and other sources of infection), stimulates the body's natural healing mechanisms, resists scarring, and – because it is quickly absorbed by surrounding tissue – may never have to be removed in follow-up ...

Children aged five and under – particularly those with intermittent viral-induced wheezing – should be treated with oral corticosteroids for asthma only if their wheeze is severe enough to require hospital admission, according to new guidelines.

New research on mice has shown that pulmonary administration of granulocyte macrophage-colony stimulating factor (GM-CSF) significantly reduces flu symptoms and prevents death after a lethal dose influenza virus. While GM-SCF therapy for humans as a flu prophylaxis or treatment may be years away, the study results were striking: All of the mice treated with GM-SCF survived after being infected ...

The World Health Organisation (WHO) must take a tougher stance on super bugs, according to a University of Queensland infectious diseases expert.